Literature DB >> 15354275

Ex vivo histology-correlated optical coherence tomography in the detection of transmural inflammation in Crohn's disease.

Bo Shen1, Gregory Zuccaro, Terry L Gramlich, Natalie Gladkova, Bret A Lashner, Conor P Delaney, Jason T Connor, Feza H Remzi, Margaret Kareta, Charles L Bevins, Felix Feldchtein, Scott A Strong, Marlene L Bambrick, Patricia Trolli, Victor W Fazio.   

Abstract

BACKGROUND AND AIMS: Distinguishing Crohn's disease (CD) from ulcerative colitis (UC) can be difficult. Transmural inflammation, a key feature of CD, cannot be assessed by conventional colonoscopy with biopsy. Optical coherence tomography (OCT) provides high-resolution, cross-sectional images of the gut wall and might become a new diagnostic tool. The aims of this study were to perform histology-correlated OCT on surgical specimens of CD and UC and to determine its diagnostic accuracy.
METHODS: Colectomy specimens from patients with a preoperative diagnosis of CD (N = 24) or UC (N = 24) were studied with OCT in the operating room. OCT and histopathology were assessed blindly, and diagnostic accuracy of OCT was assessed.
RESULTS: Eight preoperatively identified UC patients (33%) with transmural inflammation on postoperative histology were diagnosed with CD, and all 8 had a disrupted layered structure on OCT, a characteristic feature of transmural disease. Sixteen UC patients (67%) had superficial inflammation on histology; of them, 13 (81%) had an intact layered structure on OCT. All 24 preoperative CD patients had transmural inflammation on histology, and 23 (96%) had a disrupted layered structure on OCT. Of 585 histology-OCT image sets from the 48 patients, 152 sets (26%) had transmural inflammation on histology. The sensitivity and specificity for OCT to detect transmural disease were 86% and 91%, respectively.
CONCLUSIONS: Transmural inflammation, as characterized by disruption of the layered structure of colon wall on OCT, is an accurate marker for the diagnosis of CD. Ex vivo OCT predicted transmural inflammation on postoperative histopathology.

Entities:  

Mesh:

Year:  2004        PMID: 15354275     DOI: 10.1016/s1542-3565(04)00346-5

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  6 in total

1.  Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography.

Authors:  John A Evans; Brett E Bouma; Jason Bressner; Milen Shishkov; Gregory Y Lauwers; Mari Mino-Kenudson; Norman S Nishioka; Guillermo J Tearney
Journal:  Gastrointest Endosc       Date:  2006-09-20       Impact factor: 9.427

2.  Transmural inflammation is not pathognomonic for Crohn's disease of the pouch.

Authors:  Zhao-xiu Liu; Tom Deroche; Feza H Remzi; Jefferey P Hammel; Victor W Fazio; Run-zhou Ni; John R Goldblum; Bo Shen
Journal:  Surg Endosc       Date:  2011-06-10       Impact factor: 4.584

3.  Differential diagnosis of acute and chronic colitis in mice by optical coherence tomography.

Authors:  Dan Li; Shijie Ding; Manting Luo; Jinguo Chen; Qiukun Zhang; Yijuan Liu; Anlan Li; Shuncong Zhong; Jian Ding
Journal:  Quant Imaging Med Surg       Date:  2022-06

4.  Label-Free, Longitudinal Visualization of PDT Response In Vitro with Optical Coherence Tomography.

Authors:  Yookyung Jung; Alexander J Nichols; Oliver J Klein; Emmanuel Roussakis; Conor L Evans
Journal:  Isr J Chem       Date:  2012-09-13       Impact factor: 3.333

Review 5.  Imaging Inflammation - From Whole Body Imaging to Cellular Resolution.

Authors:  Tuula Peñate Medina; Jan Philip Kolb; Gereon Hüttmann; Robert Huber; Oula Peñate Medina; Linh Ha; Patricia Ulloa; Naomi Larsen; Arianna Ferrari; Magdalena Rafecas; Mark Ellrichmann; Mariya S Pravdivtseva; Mariia Anikeeva; Jana Humbert; Marcus Both; Jennifer E Hundt; Jan-Bernd Hövener
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

Review 6.  Imaging of Mucosal Inflammation: Current Technological Developments, Clinical Implications, and Future Perspectives.

Authors:  Maximilian J Waldner; Timo Rath; Sebastian Schürmann; Christian Bojarski; Raja Atreya
Journal:  Front Immunol       Date:  2017-10-11       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.